Patents by Inventor John D. Sandy

John D. Sandy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190093166
    Abstract: One aspect of the invention provides a method for classifying the quality of a repair response after injury to a joint of a human or veterinary patient including determining expression levels of at least one of a plurality of genes listed in FIG. 4(A) expressed in a tissue sample taken from the joint.
    Type: Application
    Filed: March 1, 2017
    Publication date: March 28, 2019
    Applicant: RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Anna H.K. Plaas, Deva Chan, John D. Sandy, Vincent Hascall, Katie J. Trella, Robert Wysocki, Vincent Wang, Jun Li
  • Publication number: 20180291455
    Abstract: One aspect of the invention provides methods for classifying the quality of a repair response after injury to a joint of a subject. In one embodiment, the method includes providing a tissue sample from the injured region of the joint and determining expression levels in the sample of a plurality of genes, including at least those genes listed in Table 1, Table 2 and Table 3. Another aspect of the invention provides methods of treating a human or veterinary subject having an injury to a joint based on the classification of the quality of the repair response.
    Type: Application
    Filed: May 9, 2018
    Publication date: October 11, 2018
    Applicant: RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Deva Chan, Jun Li, Anna H.K. Plaas, John D. Sandy, Vincent Wang
  • Patent number: 9994903
    Abstract: One aspect of the Invention provides methods for classifying the quality of a repair response after injury to a joint of a subject. In one embodiment, the method includes providing a tissue sample from the injured region of the joint and determining expression levels in the sample of a plurality of genes, including at least those genes listed in Table 1, Table 2 and Table 3, Another aspect of the Invention provides methods of treating a human or veterinary subject having an injury to a joint based on the classification of the quality of the repair response.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: June 12, 2018
    Assignee: RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Deva Chan, Jun Li, Anna H. K. Plaas, John D. Sandy, Vincent Wang
  • Publication number: 20170266168
    Abstract: One aspect of the invention provides a method for treating or preventing the development of osteoarthritis by administering to a subject in need of such treatment a composition including a therapeutically effective amount of an anti-fibrotic agent. In various embodiments, the anti-fibrotic agent is 5-methyl-1-phenylpyridin-2-one, tranilast, gamma-glutamyl transpeptidase inhibitor, fasudil, CC-930, T-5524, rosiglitazone, tocilizumab, E5564, TAK-242, GKT136901 or bosentan.
    Type: Application
    Filed: September 14, 2015
    Publication date: September 21, 2017
    Applicant: RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Deva Chan, Jun Li, Anna H.K. Plaas, Daniel Predescu, John D. Sandy
  • Publication number: 20160215342
    Abstract: One aspect of the Invention provides methods for classifying the quality of a repair response after injury to a joint of a subject. In one embodiment, the method includes providing a tissue sample from the injured region of the joint and determining expression levels in the sample of a plurality of genes, including at least those genes listed in Table 1, Table 2 and Table 3. Another aspect of the Invention provides methods of treating a human or veterinary subject having an injury to a joint based on the classification of the quality of the repair response.
    Type: Application
    Filed: September 8, 2014
    Publication date: July 28, 2016
    Applicant: RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Deva Chan, Jun Li, Anna H.K. Plaas, John D. Sandy, Vincent Wang
  • Patent number: 5427954
    Abstract: The subject invention concerns novel materials and methods for the detection, treatment, and prevention of human osteoarthritis. Specifically, the cleavage site where aggrecanase cleaves aggrecan has been identified. Identification of this site, as well as the nature of the enzyme, facilitates specific treatments which block or diminish the activity of the enzyme. A further aspect of the invention concerns methods for detecting evidence of osteoarthritis.
    Type: Grant
    Filed: April 29, 1992
    Date of Patent: June 27, 1995
    Assignee: Shriner's Hospitals for Crippled Children
    Inventors: John D. Sandy, Carl R. Flannery, Peter J. Neame, L. Stefan Lohmander